Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In a Phase III trial in patients 6 to 12 years, the drugs pharmacokinetic and pharmacodynamic profiles were consistent with that seen in previous studies, according to AstraZeneca
P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response
Cell Death Dis 17 , 358 (2026)
Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: a meta-analysis
US$ 20.41
US$ 20.57
US$ 23.99
US$ 24.38
US$ 23.62
US$ 25.77
US$ 22.63
US$ 24.07
US$ 22.72
US$ 26.35
US$ 28.18
US$ 25.01
US$ 26.50
